TED.L Regulatory News (TED)

15 Aug 2005 13:17

Cantor Fitzgerald Europe15 August 2005 FORM 8.3 DEALINGS BY PERSONS WHO OWN OR CONTROL 1% OR MORE OF ANY CLASS OF RELEVANT SECURITY (Rule 8.3 of The City Code on Takeovers and Mergers) Name of purchaser/vendor * Cantor Fitzgerald Europe Company dealt in Tepnel Life Sciences Plc Relevant security dealt in Ordinary Shares If a connected EFM, name of offeree/offeror N/Awith which connected If a connected EFM, nature of connection # N/A Date of dealing 12th August 2005 DEALINGS + Amount bought Price per unit (currency must be stated) 550,000 8.5 Amount sold Price per unit (currency must be stated) Resultant total amount and percentage of the 2,450,000 1.15%same relevant security owned or controlled IS A SUPPLEMENTAL FORM 8 (DERIVATIVE)/FORM 8 (OPTION) ATTACHED? YES Date of disclosure 15th August 2005 Contact name Claire Swaby Telephone number 020 7894 7990 * Specify the owner or controller in addition to the person dealing. The naming of nominees or vehicle companies is insufficient. In the case of disclosure of dealings by fund managers on behalf of discretionary clients, the clients need not be named. # See the definition of "connected fund managers and principal traders" in the Definitions Section of the Code. + If disclosing dealings/holdings in derivatives or options, please attach Supplemental Form 8 (Derivative) or Supplemental Form 8 (Option), as appropriate. For details of the Code's dealing disclosure requirements, see Rule 8 and itsNotes which can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk. SUPPLEMENTAL FORM 8 (DERIVATIVE) DEALINGS/HOLDINGS IN DERIVATIVES (This form should be attached to Form 8.1, Form 8.1(b)(ii), Form 8.2 or Form 8.3, as appropriate) Description of all derivative Cantor Fitzgerald Europe is the beneficial products disclosed on this form owner of 2,450,000 Tepnel Life Sciences PLC ordinary shares. These shares are held to hedge Contract for Differences ("CFD"). A Long CFD is a product where the client to whom the product is sold is taking a long economic interest in the underlying share price such that the client can realise a gain if the price of the underlying securities rises above the reference price. A purchaser of a CFD contract will realise a gain if the price of the underlying security goes up. A seller of a CFD contract will realise a gain if the price of the underlying security goes down. Full details of any agreement, arrangement or understanding between the person disclosing and any otherperson relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. none WRITING/ENTERING INTO A DERIVATIVE Product name Transaction Writing/entering Number of Reference Maturity eg long CFD date into (indicate securities price date as applicable) to which the (currency derivative is must be referenced stated)Tepnel Life SciencesPlc, Long CFD 12/08/05 Written 550,000 8.5 CLOSING OUT A DERIVATIVE Product name Transaction Number of securities Reference Closing out price eg long CFD date to which the price (currency must be derivative is (currency stated) referenced must be stated) DETAILS OF OPEN DERIVATIVES (excluding any transaction set out above) Product name Transaction Written/entered Number of Reference Maturity eg long CFD date into (indicate securities to price date as applicable) which the (currency derivative is must be referenced stated) Tepnel Life 19/07/05 Written 700,000 9.5Sciences Plc, Long CFD Tepnel LifeSciencesPlc, Long CFD 25/07/05 Written 1,000,000 9 Tepnel LifeSciencesPlc, Long CFD 10/08/05 Written 200,000 9.5 For details of the Code's dealing disclosure requirements, see Rule 8 and itsNotes which can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk. This information is provided by RNS The company news service from the London Stock Exchange